Envisagenics, Inc. — Form D/A
Envisagenics, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2017-10-30. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-10-30
- Form: D/A
- Accession: 0001144204-17-054703
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 6
- Date of first sale: 2017-03-16
- Revenue range: Decline to Disclose
- SEC file number: 021-281766
Issuer
- Name: Envisagenics, Inc.
- CIK: 0001699688
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 101 6TH AVENUE, NEW YORK, NY, 10013
- Phone: 929-777-2001
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| MARTIN LUISA AKERMAN | Promoter | NEW YORK, NY |
| MARIA LUISA PINEDA | Promoter | NEW YORK, NY |
| Alan S Roemer | Director | New York, NY |
| BRADLEY S HARRIS | Executive Officer | NEW YORK, NY |
| MARTIN LUISA AKERMAN | Director | NEW YORK, NY |
| MARTIN LUISA AKERMAN | Executive Officer | NEW YORK, NY |
| GRANT LUISA VERSTANDING | Director | BEVERLY HILLS, CA |
| MARIA LUISA PINEDA | Director | NEW YORK, NY |
| MARIA LUISA PINEDA | Executive Officer | NEW YORK, NY |
Other filings by this issuer (2)
More